To our knowledge, our study is the first time to report the role of SLC38A6 in patients with pneumonia and sepsis-associated pulmonary inflammation in mice, which provides a new possibility for the study of the function of amino acid transporters, and also provides a potential molecular target for the treatment of bacterial pneumonia and sepsis-associated pulmonary inflammation. Here, SLC38A6 is linked to pneumonia.